First reports of serious adverse drug reactions in recent weeks

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.21, Iss.7, 2005-07, pp. : 20-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The following table contains an overview of first published case reports of serious adverse drug reactions (ADRs) identified in the international literature in recent weeks by the drug safety alerting service Reactions Weekly. An event is serious (FDA MedWatch definition) when the patient outcome is death, life-threatening, hospitalisation, disability, congenital anomaly or requires intervention to prevent permanent impairment or damage. Summarising information selected from over 1700 biomedical publications, Reactions Weekly is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details.

Related content

First reports of serious adverse drug reactions in recent weeks

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 1, 2011-01 ,pp. : 21-22 (2)

Adis International

Access to resources Recommend Favorite

First reports of serious adverse drug reactions in recent weeks

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 2, 2011-02 ,pp. : 17-17 (1)

Adis International

Access to resources Recommend Favorite

First reports of serious adverse drug reactions in recent weeks

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 5, 2006-05 ,pp. : 19-20 (2)

Adis International

Access to resources Recommend Favorite

First reports of serious adverse drug reactions in recent weeks

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 6, 2011-06 ,pp. : 22-22 (1)

Adis International

Access to resources Recommend Favorite

First reports of serious adverse drug reactions in recent weeks

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 8, 2006-08 ,pp. : 23-23 (1)

Adis International

Access to resources Recommend Favorite